Shares of 111 Inc – (NASDAQ:YI) have been assigned a consensus broker rating score of 1.00 (Strong Buy) from the one analysts that cover the stock, Zacks Investment Research reports. One research analyst has rated the stock with a strong buy recommendation.

Brokerages have set a one year consensus target price of $14.00 for the company, according to Zacks. Zacks has also given 111 an industry rank of 97 out of 256 based on the ratings given to its competitors.

YI stock traded up $1.91 during trading on Tuesday, reaching $4.99. The company had a trading volume of 1,868,454 shares, compared to its average volume of 40,672. 111 has a 52 week low of $2.29 and a 52 week high of $16.83. The business has a 50 day moving average of $3.14 and a 200 day moving average of $6.20. The company has a market cap of $187.55 million and a P/E ratio of -4.50.

111 (NASDAQ:YI) last posted its earnings results on Thursday, August 15th. The company reported ($0.18) earnings per share for the quarter. 111 had a negative return on equity of 39.18% and a negative net margin of 18.45%. The firm had revenue of $122.09 million for the quarter. Analysts forecast that 111 will post -1.32 earnings per share for the current year.

111 Company Profile

111, Inc, through its subsidiaries, operates an integrated online and offline platform in the healthcare market in the People's Republic of China. The company sells medical and wellness products through online retail, and wholesale and retail pharmacies, as well as provides value-added services, such as online consultation services and e-prescription services to consumers.

Featured Article: What does the Dogs of the Dow mean?

Get a free copy of the Zacks research report on 111 (YI)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for 111 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 111 and related companies with's FREE daily email newsletter.